Noticias de Eulerpool Atara Biotherapeutics

Atara Biotherapeutics Eulerpool-AFX

Atara Biotherapeutics Noticias de Acciones

Atara Biotherapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Atara Biotherapeutics.

• 19 de julio ·

  Yahoo
  US FDA grants priority review for Pierre Fabre’s EBV+ PTLD
• 18 de julio ·

  Thefly.com
  Biotech Alert: Searches spiking for these stocks today
• 18 de julio ·

  TipRanks
  Atara Biotherapeutics Receives Buy Rating Amidst Positive FDA Review and Solid Financial Outlook
• 17 de julio ·

  Yahoo
  FDA priority review advances Atara’s tabelecleucel for viral infection
• 17 de julio ·

  Yahoo
  Atara Biotherapeutics Announces U.S. FDA Acceptance and Priority Review of the Biologics License Application for Tabelecleucel (Tab-cel®) for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease
• 17 de julio ·

  Yahoo
  Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now
• 17 de julio ·

  Thefly.com
  Atara announces $20M milestone from Pierre Fabre amid filing of tab-cel BLA
• 17 de julio ·

  Seeking Alpha
  Atara lead asset tab-cel undergoes FDA priority review
• 15 de julio ·

  Yahoo
  All You Need to Know About Atara Biotherapeutics (ATRA) Rating Upgrade to Strong Buy
• 5 de julio ·

  Yahoo
  Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)